Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and S-1 in Advanced Esophageal Cancer
NCT01693432Phase 2Unknown
- Sponsor
- Hallym University Medical Center
- Start
- Nov 2011
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, tegafur in esophageal cancer, sponsored by Hallym University Medical Center. Status: unknown.
02
Drugs
docetaxeltegafur
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT01693432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01693432.